John Yarnold

19.4k citations

193 papers · 10.4k indexed · 4 hit papers · h-index 50

Radiation top 0.05%
- Advanced Radiotherapy Techniques 52
Cancer Research top 0.1%
- Breast Cancer Treatment Studies 106
Radiology, Nuclear Medicine and Imaging top 0.2%
- Effects of Radiation Exposure 34
- Advances in Oncology and Radiotherapy 20
Oncology top 0.5%
- Global Cancer Incidence and Screening 23
Otorhinolaryngology top 0.5%
- Head and Neck Cancer Studies 12
Pathology and Forensic Medicine
- Breast Lesions and Carcinomas 25
Surgery
- Breast Implant and Reconstruction 14

Co-authors: Joanne Haviland Judith M. Bliss Marie‐Catherine Vozenin Philip Evans Ellen M. Donovan John R. Owen Søren M. Bentzen Peter Hoskin
Cited by: Radiation Cancer Research Radiology, Nuclear Medicine and Imaging
Journals: Radiotherapy and Oncology (70 papers)Clinical Oncology (21 papers)British Journal of Radiology (10 papers)
Partner nations: United Kingdom United States Germany

In The Last Decade

John Yarnold

187 papers receiving 10.1k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2015 Radiotherapy and Oncology
2013 The Lancet Oncology
2010 Radiotherapy and Oncology
1999 The Lancet

Peers

Countries citing papers authored by John Yarnold

Since Specialization

Citations

This map shows the geographic impact of John Yarnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Yarnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Yarnold more than expected).

Fields of papers citing papers by John Yarnold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Yarnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Yarnold. The network helps show where John Yarnold may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John Yarnold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John Yarnold Line = papers co-authored together John Yarnold links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Partial-breast radiotherapy after breast conservation surgery for women with early breast cancer (UK IMPORT LOW): 10-year outcomes from a multicentre, open-label, randomised, controlled, phase 3, non-inferiority trial The Lancet Oncology ·Anna M. Kirby,Laura Finneran,Clare Griffin,Adrian Murray Brunt,Fay Cafferty,Abdulla Alhasso,Charlie Chan,Joanne Haviland,Monica Jefford,Elinor J. Sawyer,Mark Sydenham,Isabel Syndikus,Y. Tsang,Duncan Wheatley,John Yarnold,Charlotte E. Coles,Judith M. Bliss	2025	0
2	Abstract PO5-22-04: Genomic analysis of local recurrences following risk adapted breast radiotherapy in the IMPORT trials defines 'true recurrences' and 'new primaries' Cancer Research ·Sara Lightowlers,E. Braun,Elena Provenzano,Judith M. Bliss,Jason S. Carroll,Hui Pana,Clare Griffin,Joanne Haviland,Monica Jefford,Anna M. Kirby,Navita Somaiah,Mark Sydenham,Jenny Titley,John Yarnold,Charlotte E. Coles,Elinor J. Sawyer	2024	1
3	Partial Breast Radiotherapy for Women with Early Breast Cancer: 10-Year Outcomes from IMPORT LOW (CRUK/06/003) International Journal of Radiation OncologyBiologyPhysics ·Anna M. Kirby,Clare Griffin,Laura Finneran,Mark Sydenham,Abdulla Alhasso,Adrian Murray Brunt,Hsiao Yun Chan,Monica Jefford,Jerome M Jamilo,Isabel Syndikus,Y. Tsang,Duncan Wheatley,John Yarnold,Charlotte E. Coles,Judith M. Bliss	2023	0
4	Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials Radiotherapy and Oncology ·Joanne Haviland,Mariella Mannino,Clare Griffin,Núria Porta,Mark Sydenham,Judith M. Bliss,John Yarnold	2017	55
5	Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial Radiotherapy and Oncology ·Adrian Murray Brunt,Duncan Wheatley,John Yarnold,Navita Somaiah,Stephen Kelly,Adrian Harnett,Charlotte E. Coles,Andrew Goodman,Amit Bahl,Mark Churn,Clement Obuene,Mark Sydenham,Clare Griffin,James P. Morden,Judith M. Bliss	2016	149
6	Patients with a High Polygenic Risk of Breast Cancer do not have An Increased Risk of Radiotherapy Toxicity Clinical Cancer Research ·Leila Dorling,Gillian C. Barnett,Kyriaki Michailidou,Charlotte E. Coles,N.G. Burnet,John Yarnold,Rebecca Elliott,Alison M. Dunning,Paul D.P. Pharoah,Catharine West	2015	15
7	IMPORT Trial Management Group. Clinical impact of IMPORT HIGH trial (CRUK/06/003) on breast radiotherapy practices in the United Kingdom. British Journal of Radiology ·Y. Tsang,L. Ciurlionis,Cliona Kirwan,Anna M. Kirby,Imogen Locke,Karen Venables,John Yarnold,Jenny Titley,Judith M. Bliss,Charlotte E. Coles	2015	42
8	Where Do We Look for Markers of Radiotherapy Fraction Size Sensitivity? Clinical Oncology ·Navita Somaiah,Kai Rothkamm,John Yarnold	2015	10
9	Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy Journal of Visualized Experiments ·Frederick R. Bartlett,R. Colgan,Ellen M. Donovan,Karen Carr,مهدی بیگدلو,Steven N. Maidment,H. McNair,Imogen Locke,Philip Evans,Joanne Haviland,John Yarnold,Anna M. Kirby	2014	9
10	The Relationship Between Homologous Recombination Repair and the Sensitivity of Human Epidermis to the Size of Daily Doses Over a 5-Week Course of Breast Radiotherapy Clinical Cancer Research ·Navita Somaiah,John Yarnold,Frances Daley,Xiaochen Li,Lone Gothard,Kai Rothkamm,Thomas Helleday	2012	24
11	Does Participation in Clinical Trials Influence the Implementation of New Techniques? A Look at Changing Techniques in Breast Radiotherapy in the UK Clinical Oncology ·Karen Venables,Y. Tsang,L. Ciurlionis,Charlotte E. Coles,John Yarnold	2012	10
12	Second cancer incidence risk estimates using BEIR VII models for standard and complex external beam radiotherapy for early breast cancer Medical Physics ·Ellen M. Donovan,Hitoshi HORIYAMA,Maria Bonora,John Yarnold,Philip Evans	2012	56
13	How does knowledge of three-dimensional excision margins following breast conservation surgery impact upon clinical target volume definition for partial-breast radiotherapy? Radiotherapy and Oncology ·Anna M. Kirby,Philip Evans,Ashutosh Nerurkar,Bailey Pascuzzi,Jarosław Krupa,Haresh Devalia,G. Querci della Rovere,Emma Harris,ペーターレーゼル,John Yarnold	2009	17
14	Double-blind, placebo-controlled, randomised phase II trial of IH636 grape seed proanthocyanidin extract (GSPE) in patients with radiation-induced breast induration Radiotherapy and Oncology ·賢一広沢,Susan Martin,Xiaochen Li,Debasis Bagchi,Judith Earl,Lone Gothard,Emma Hall,修三内藤,John Yarnold	2006	37
15	Phase II study of vitamin E and pentoxifylline in patients with late side effects of pelvic radiotherapy Radiotherapy and Oncology ·Lone Gothard,Paul Cornes,賢一広沢,Judith Earl,J.P. Glees,Emma Hall,Clare Peckitt,Diana Tait,John Yarnold	2005	41
16	Non-randomised phase II trial of hyperbaric oxygen therapy in patients with chronic arm lymphoedema and tissue fibrosis after radiotherapy for early breast cancer Radiotherapy and Oncology ·Lone Gothard,A.W.B. Stanton,磯崎勝吾,David Lawrence,Emma Hall,Peter Mortimer,Gabriel Sayago,Jean-Jacques Baloula,Jong-Koo 유종구Yoo,Robert G. Sawyer,Mary Woods,John Yarnold	2003	63
17	Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: Results of a multicentre randomised trial European Journal of Cancer ·A. Gregor,A. Cull,Richard Stephens,John A. Kirkpatrick,John Yarnold,D.J. Girling,Fergus Macbeth,R. Stout,David Machin	1997	260
18	Molecular biology for clinical oncologists (2nd ed.) Lancaster EPrints (Lancaster University) ·John Yarnold,K Wetzer,Trevor J. McMillan	1996	1
19	Benefits expected from simple conformal radiotherapy in the treatment of pelvic tumours Radiotherapy and Oncology ·Diana Tait,Alan E. Nahum,Kirstin E. Wells,Donald R. Loudon,John Yarnold	1988	20
20	Prospective randomised trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases Radiotherapy and Oncology ·P. Price,Peter Hoskin,Douglas F. Easton,Paolo Guagnano,S. Palmer,John Yarnold	1986	343

About John Yarnold

John Yarnold is a scholar working on Cancer Research, Radiation and Radiology, Nuclear Medicine and Imaging, having authored 193 papers that have together received 10.4k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (106 papers), Advanced Radiotherapy Techniques (52 papers), Effects of Radiation Exposure (34 papers), Breast Lesions and Carcinomas (25 papers), Global Cancer Incidence and Screening (23 papers), Advances in Oncology and Radiotherapy (20 papers), Breast Implant and Reconstruction (14 papers) and Head and Neck Cancer Studies (12 papers). The work is most often cited by research in Radiation (3.6k citations), Cancer Research (5.2k citations) and Radiology, Nuclear Medicine and Imaging (3.5k citations). John Yarnold has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Joanne Haviland, Judith M. Bliss, Marie‐Catherine Vozenin, Philip Evans, Ellen M. Donovan, John R. Owen, Søren M. Bentzen, Peter Hoskin, Anna M. Kirby and J. Regan. Their work appears in journals such as Radiotherapy and Oncology, Clinical Oncology, British Journal of Radiology, International Journal of Radiation Oncology*Biology*Physics and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact